Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting.
about
Silencing NFBD1/MDC1 enhances the radiosensitivity of human nasopharyngeal cancer CNE1 cells and results in tumor growth inhibition.Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.Recombinant elastin-based nanoparticles for targeted gene therapy.Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia
P2860
Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting.
@en
type
label
Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting.
@en
prefLabel
Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting.
@en
P2093
P2860
P356
P1433
P1476
Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting
@en
P2093
D Redaelli
F Benedicenti
F Dionisio
P2860
P2888
P304
P356
10.1038/GT.2015.10
P577
2015-03-12T00:00:00Z
P6179
1012233214